← Leaderboards
Laura L Worth
University Of Texas Md Anderson Can Ctr
$680,400
Attributed
$680,400
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $136.1K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$680,400 · 1
By mechanism
K08$680,400 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Stephen E Ullrich$5,147,419
- Konstantin V Sokolov$9,178,408
- Scott M Lippman$54,535,308
- Feng Jiang$3,317,251
- Veronique M Lefebvre$17,895,341
Others in their field
Top investigators on “Macrophage”
- Craig B Thompson · Sloan-Kettering Inst Can Research$41,669,179
- Howard Eliot Gendelman · Children'S Memorial Hospital (Chicago)$41,668,744
- Selwyn M Vickers · University Of Alabama At Birmingham$40,969,055
- Alan A Aderem · University Of Washington$38,969,733
- Alan Richard Tall · Columbia University Health Sciences$38,053,695
- John S Condeelis · Yeshiva University$33,855,255
Research focus
MacrophageNatural Killer CellsHelper T LymphocyteT Cell ReceptorInterleukin 12Cytotoxic T LymphocyteOsteosarcomaLeukocyte Activation /TransformationGene TherapyAthymic MouseNeoplasm /Cancer ImmunotherapyClinical ResearchBiotechnologyMetastasisNonhuman Therapy EvaluationAntigen PresentationCell MigrationLung NeoplasmsGene Delivery SystemCell Growth RegulationInterferon GammaIntravenous AdministrationImmunocytochemistryDendrites
Grant awards (6)
IL-12 Gene Therapy for Metastatic Osteosarcoma$68,040
K08 · FY2007 · CA · contact PI
IL-12 Gene Therapy for Metastatic Osteosarcoma$136,080
K08 · FY2006 · CA · contact PI
IL-12 Gene Therapy for Metastatic Osteosarcoma$136,080
K08 · FY2005 · CA
IL-12 Gene Therapy for Metastatic Osteosarcoma$136,080
K08 · FY2004 · CA
IL-12 Gene Therapy for Metastatic Osteosarcoma$136,080
K08 · FY2003 · CA
IL-12 Gene Therapy for Metastatic Osteosarcoma$68,040
K08 · FY2002 · CA